Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.
Bandyopadhyay A, López-Casillas F, Malik SN, Montiel JL, Mendoza V, Yang J, Sun LZ. Bandyopadhyay A, et al. Cancer Res. 2002 Aug 15;62(16):4690-5. Cancer Res. 2002. PMID: 12183427
Bandyopadhyay et al., Cancer Res., 59: 5041-5046, 1999). In the current study, we investigated the potential therapeutic utility of a recombinant preparation of human and rat soluble betaglycan (sBG). ...As such, it could be a useful therapeutic agent to anta …
Bandyopadhyay et al., Cancer Res., 59: 5041-5046, 1999). In the current study, we investigated the potential therapeutic utility of …
Significance of PELP1 in ER-negative breast cancer metastasis.
Roy S, Chakravarty D, Cortez V, De Mukhopadhyay K, Bandyopadhyay A, Ahn JM, Raj GV, Tekmal RR, Sun L, Vadlamudi RK. Roy S, et al. Among authors: bandyopadhyay a. Mol Cancer Res. 2012 Jan;10(1):25-33. doi: 10.1158/1541-7786.MCR-11-0456. Epub 2011 Nov 15. Mol Cancer Res. 2012. PMID: 22086908 Free PMC article.
Aging is associated with an expansion of CD49fhi mammary stem cells that show a decline in function and increased transformation potential.
Dong Q, Gao H, Shi Y, Zhang F, Gu X, Wu A, Wang D, Chen Y, Bandyopadhyay A, Yeh IT, Daniel BJ, Chen Y, Zou Y, Rebel VL, Walter CA, Lu J, Huang C, Sun LZ. Dong Q, et al. Among authors: bandyopadhyay a. Aging (Albany NY). 2016 Nov 15;8(11):2754-2776. doi: 10.18632/aging.101082. Aging (Albany NY). 2016. PMID: 27852980 Free PMC article.
Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models.
Bandyopadhyay A, Favours E, Phelps DA, Pozo VD, Ghilu S, Kurmashev D, Michalek J, Trevino A, Guttridge D, London C, Hirotani K, Zhang L, Kurmasheva RT, Houghton PJ. Bandyopadhyay A, et al. Pediatr Blood Cancer. 2018 Feb;65(2):10.1002/pbc.26870. doi: 10.1002/pbc.26870. Epub 2017 Oct 28. Pediatr Blood Cancer. 2018. PMID: 29080385 Free PMC article.
Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models.
Kurmasheva RT, Bandyopadhyay A, Favours E, Del Pozo V, Ghilu S, Phelps DA, Erickson SW, Peer CJ, Figg WD, Smith MA, Houghton PJ. Kurmasheva RT, et al. Among authors: bandyopadhyay a. Pediatr Blood Cancer. 2019 Aug;66(8):e27820. doi: 10.1002/pbc.27820. Epub 2019 May 16. Pediatr Blood Cancer. 2019. PMID: 31099166 Free PMC article.
Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortium.
Kurmasheva RT, Bandyopadhyay A, Favours E, Pozo VD, Ghilu S, Phelps DA, McGeehan GM, Erickson SW, Smith MA, Houghton PJ. Kurmasheva RT, et al. Among authors: bandyopadhyay a. Pediatr Blood Cancer. 2020 Jul;67(7):e28284. doi: 10.1002/pbc.28284. Epub 2020 Apr 25. Pediatr Blood Cancer. 2020. PMID: 32333633 Free PMC article.
1,244 results